Search

Search Results

1. Hepatitis C virus core antigen: A diagnostic and treatment monitoring marker of hepatitis C virus in Indian population

   Background

   The diagnosis and treatment monitoring of hepatitis C is quite challenging. The screening test, i.e. antibody assay, is unable to detect...

   Jaya Garg, Prashant Verma, ... Jyotsna Agarwal in Indian Journal of Gastroenterology

   Article 15 April 2024
   

2. Hepatitis C Virus

   Viral hepatitis is a major cause of illness and mortality across the world. Hepatitis C virus (HCV) is transmitted parenterally and can cause acute...

   Ameer Abutaleb, Shyam Kottilil, Elana Rosenthal in Viral Infections of Humans

   Living reference work entry 2022
   

3. Management of Hepatitis C Virus: Current and Future Treatments

   Globally, hepatitis C virus (HCV), the most important health issue, is a meticulous factor in liver disease. Its cure is now possible for most people...

   Disha Arora, Smriti Parashar, Rupesh K. Gautam in Recent Advances in Pharmaceutical Innovation and Research

   Chapter 2023
   

4. High prevalence of hepatitis B virus susceptibility among persons undergoing community-based hepatitis C virus treatment

   Background

   Due to shared modes of transmission, coinfection with hepatitis B virus (HBV) and hepatitis C virus (HCV) is common, and HBV vaccination is...

   Catherine Campusano, Rachel Kanner, ... Jennifer C. Price in Harm Reduction Journal

   Article Open access 29 January 2024
   

5. Outcome of direct-acting antiviral treatment in patients with hepatitis C virus/hepatitis B virus coinfection

   Background

   Oral direct-acting antiviral (DAA) regimens for chronic hepatitis C virus (HCV) infection have greatly improved treatment efficacy, with...

   El-Araby Mohamed Ibrahim Shalaby, Eman Abdelsameea, ... Imam Waked in Egyptian Liver Journal

   Article Open access 28 June 2023

6. Assessing and Counseling a Patient with Hepatitis C Virus (HCV) Infection

   Areas to be focused on: Risk factors to develop hepatitis C infection, management of hepatitis C infection, and the complication of hepatitis C and...

   Kawthar Al Ameri, Sumiya Taheri, Shammah Al Memari in Family Medicine OSCE: First Aid to Objective Structured Clinical Examination

   Chapter 2024
   

7. Reverse Genetics of Hepatitis C Virus Using an RNA Polymerase I-Mediated Transcription

   The reverse genetics system commonly used for the production of hepatitis C virus (HCV), which is a major causative agent of liver diseases, involves...

   Ryosuke Suzuki, Tetsuro Suzuki in Reverse Genetics of RNA Viruses

   Protocol 2024
   

8. Hepatitis E Virus (HEV)

   HEV belongs to family Hepeviridae. The two genera are Orthohepevirus and Piscihepevirus. All mammalian and avian isolates belong to the former. The...

   Krishna Gopal Narayan, Dharmendra Kumar Sinha, Dhirendra Kumar Singh in Veterinary Public Health & Epidemiology

   Chapter 2023
   

9. Hepatitis E Virus

   The causative agent of hepatitis E, hepatitis E virus (HEV), is a small positive-sense RNA virus that is classified in the family Hepeviridae. The...

   **ang-** Meng in Viral Infections of Humans

   Living reference work entry 2023
   

10. Unraveling IL-17 and IL-22 role in occult hepatitis C versus chronic hepatitis C virus infection

    Background

    Cytokines play a crucial role in regulating the function of the immune system by controlling the production, differentiation, and activity...

    Sherif Elbaz, Nasser Mousa, ... Alaa Habib in BMC Infectious Diseases

    Article Open access 25 January 2024
    

11. Prevalence, incidence, and outcomes of hepatitis E virus coinfection in patients with chronic hepatitis C

    This study aimed to elucidate the anti-hepatitis E virus (HEV) immunoglobulin G (IgG) prevalence and incidence of seroconversion and seroreversion as...

    Eun Sun Jang, Gwang Hyeon Choi, ... Sook-Hyang Jeong in Scientific Reports

    Article Open access 21 August 2023
    

12. Global Hepatitis C Virus Elimination — Where Are We?

    Purpose of Review

    The study aims to provide an overview of hepatitis C virus (HCV) elimination strategies and actions to show the progression of...

    Mohamed Abdallah, Imam Waked, Mohamed El-Kassas in Current Hepatology Reports

    Article 14 February 2024

13. Control analysis of fractional-order extracellular delayed Hepatitis C virus model

    In this study, we develop a fractional-order model to explore the dynamics of Hepatitis C Virus (HCV) model in the conjunction with antibodies. We...

    P. Chandrika, C. Rajivganthi in The European Physical Journal Special Topics

    Article 17 June 2024
    

14. Hepatitis E Virus

    Since the sequence of hepatitis E virus (HEV) was determined from a patient with enterically transmitted non-A, non-B hepatitis in 1989, similar...

    Youchun Wang, Chenyan Zhao, ... Yansheng Geng in Hepatitis E Virus

    Chapter 2023
    

15. Feature Reduced Anova Element Oversampling Elucidation Based Categorisation for Hepatitis C Virus Prognostication

    Hepatitis C virus is a virus-borne infection that attacks the liver and causes inflammation. Disease infection is caused due to exposure to...

    M. Shyamala Devi, S. Vinoth Kumar, ... Venna Sri Sai Rajesh in Proceedings of International Conference on Recent Trends in Computing

    Conference paper 2023
    

16. Assessing Physicians’ Recommendations for Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Testing Among Minority Populations in Greater Philadelphia and New York City

    Deaths from liver cancer are on the rise and disproportionately affect minority racial/ethnic groups. In this study, we examined associations between...

    Thoin F. Begum, Vidya S Patil, ... Yin Tan in Journal of Community Health

    Article 29 January 2024

17. Hepatitis A Virus

    Hepatitis A virus (HAV) produces a preventable, self-limited necro-inflammatory disease of the liver. This noncytopathic, hepatotropic RNA virus...

    Daniel Shouval, Oren Shibolet in Viral Infections of Humans

    Living reference work entry 2023
    

18. Reactivation of hepatitis C virus caused by steroid monotherapy for sudden deafness

    Hepatitis C virus (HCV) reactivation has been reported to be caused due to several anticancer drugs and immunosuppressive agents; however, HCV...

    Hiroki Kaneko, Yoshinori Ozono, ... Hiroshi Kawakami in Clinical Journal of Gastroenterology

    Article Open access 08 April 2024
    

19. Hepatitis E Virus Zoonotic Axis

    Viral hepatitis is primarily caused by five unrelated hepatotropic viruses, hepatitis A, B, C, D, and E. While hepatitis A through C are commonly...

    Kush Kumar Yadav, Scott P. Kenney in Zoonoses: Infections Affecting Humans and Animals

    Reference work entry 2023
    

20. Direct Antiviral Agents for Hepatitis C

    The development of direct antiviral agents (DAA) for treatment of chronic hepatitis C infection is one of the greatest achievements in medical...

    I. W. Fong in New Antimicrobials: For the Present and the Future

    Chapter 2023